Clinical Trial Update: Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder [Phase 3]

View source ↗

Summary

Phase 3 trial update on GSK1358820 for overactive bladder reports results and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• GSK1358820

Snippet

Sponsor: GlaxoSmithKline | Conditions: Urinary Bladder, Overactive | Phase 3 | Status: COMPLETED | Results posted: 2019-06-03